Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change.

Beliaev, Andrei M; Allen, Sara J; Milsom, Paget; Nand, Parma; Smith, Warren M; Bergin, Colleen J

Beliaev, Andrei M; Allen, Sara J; Milsom, Paget; Nand, Parma; Smith, Warren M; Bergin, Colleen J.

Afiliação

Beliaev AM; Green Lane Cardiothoracic Surgical Unit, Auckland City Hospital, University of Auckland, Auckland, New Zealand.
Allen SJ; Cardiothoracic and Vascular Intensive Care Unit and Department of Anaesthesia, Auckland City Hospital, University of Auckland, Auckland, New Zealand.
Milsom P; Green Lane Cardiothoracic Surgical Unit, Auckland City Hospital, University of Auckland, Auckland, New Zealand.
Nand P; Green Lane Cardiothoracic Surgical Unit, Auckland City Hospital, University of Auckland, Auckland, New Zealand.
Smith WM; Cardiology Department, Auckland City Hospital, University of Auckland, Auckland, New Zealand.
Bergin CJ; Anatomy with Medical Imaging, University of Auckland, Auckland, New Zealand.

Blood Transfus ; 16(1): 53-62, 2018 01.

Article em En | MEDLINE | ID: mdl-27893353

Assuntos

Anemia/tratamento farmacológico; Bases de Dados Factuais; Eritropoetina/administração & dosagem; Testemunhas de Jeová; Adulto; Idoso; Anemia/sangue; Anemia/mortalidade; Intervalo Livre de Doença; Eritropoetina/efeitos adversos; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos; Taxa de Sobrevida

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Bases de Dados Factuais / Eritropoetina / Testemunhas de Jeová / Anemia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Transfus Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google